O'Shaughnessy Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.13M	Buy	131,177 +5,515	+4%	+$170K	0.02%	547
2026 Q1	$3.4M	Buy	125,662 +17,673	+16%	+$594K	0.02%	654
2025 Q4	$4.63M	Buy	107,989 +95,605	+772%	+$3.6M	0.03%	536
2025 Q3	$351K	Buy	+12,384	New	+$370K	﹤0.01%	1670
2022 Q2	–	Sell	-1,038	Closed	-$31K	–	1339
2022 Q1	$31K	Hold	1,038	–	–	﹤0.01%	1196
2021 Q4	$27K	Hold	1,038	–	–	﹤0.01%	1201
2021 Q3	$38K	Buy	+1,038	New	+$40.9K	﹤0.01%	1758

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's RIGL Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Rigel Pharmaceuticals (RIGL) stake by 4.4% in Q2 2026, buying an estimated $170K and bringing the position to 131,177 shares worth $5.13M. The position accounts for 0.02% of the portfolio, ranked #547.

O'Shaughnessy Asset Management first reported a position in RIGL in Q3 2021 and has held it in 7 quarters since. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

O'Shaughnessy Asset Management held 131,177 shares of Rigel Pharmaceuticals worth $5.13M as of Q2 2026.
O'Shaughnessy Asset Management bought 5,515 Rigel Pharmaceuticals shares in Q2 2026, an estimated $170K.
Rigel Pharmaceuticals made up 0.02% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #547 holding.
O'Shaughnessy Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2021 and has held it in 7 quarters since.
155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.